EIX vs ZYME · P/E 7.3, rev $17.60B vs rev $76.3M
Edison International (EIX) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the EIX and ZYME stock pages for the full models.
Not investment advice.